We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Charter Hall Group is a reit-diversified business based in Australia. Charter Hall shares (CHC) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian Dollars. Charter Hall has a trailing 12-month revenue of around $1 billion. If you're looking to buy shares, check out the steps below.
Our top pick for
US stocks
Our top pick for
ETF investing
Our top pick for
Overall broker
| 52-week range | $11.3873 - $19.155 |
|---|---|
| 50-day moving average | $17.4997 |
| 200-day moving average | $15.7573 |
| Target price | $20.38 |
| PE ratio | 16.673 |
| Dividend yield | $0.379 (2.19%) |
| Earnings per share (TTM) | $1.055 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the last close of A$17.63
| 1 week (2021-10-20) | 3.40% |
|---|---|
| 1 month (2021-09-28) | 0.74% |
| 3 months (2021-07-28) | 9.98% |
| 6 months (2021-04-28) | 24.68% |
| 1 year (2020-10-27) | 40.93% |
|---|---|
| 2 years (2019-10-25) | 50.56% |
| 3 years (2018-10-26) | 156.25% |
| 5 years (2016-10-27) | 274.31% |
Valuing Charter Hall stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Charter Hall's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Charter Hall's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 17x. In other words, Charter Hall shares trade at around 17x recent earnings.
That's relatively low compared to, say, the P/E ratio for the ASX over the 12 months to December 2019 (32.14). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Charter Hall's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $580 million (£0.0 million).
The EBITDA is a measure of a Charter Hall's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $1 billion |
|---|---|
| Operating margin TTM | 56.43% |
| Gross profit TTM | $327.9 million |
| Return on assets TTM | 11.8% |
| Return on equity TTM | 21.3% |
| Profit margin | 49% |
| Book value | 5.091 |
| Market capitalisation | $24.6 billion |
TTM: trailing 12 months
Dividend payout ratio: 65.2% of net profits
Recently Charter Hall has paid out, on average, around 65.2% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 2.1% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Charter Hall shareholders could enjoy a 2.1% return on their shares, in the form of dividend payments. In Charter Hall's case, that would currently equate to about A$0.379 per share.
Charter Hall's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
The latest dividend was paid out to all shareholders who bought their shares by 28 June 2021 (the "ex-dividend date").
Charter Hall's shares were split on a 1:4 basis on 11 November 2010. So if you had owned 4 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Charter Hall shares – just the quantity. However, indirectly, the new 300% higher share price could have impacted the market appetite for Charter Hall shares which in turn could have impacted Charter Hall's share price.
Over the last 12 months, Charter Hall's shares have ranged in value from as little as $11.3873 up to $19.155. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Charter Hall's is 1.0262. This would suggest that Charter Hall's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
With over 30 years' experience in property investment and funds management, we're one of Australia's leading fully integrated property groups. We use our property expertise to access, deploy, manage and invest equity across our core sectors ? office, retail, industrial & logistics and social infrastructure. Operating with prudence, we've carefully curated a $41.8 billion plus diverse portfolio of over 1100 high quality, long leased properties. Partnership and financial discipline are at the heart of our approach. Acting in the best interest of customers and communities, we combine insight and inventiveness to unlock hidden value. Taking a long term view, our $6.8 billion development pipeline delivers sustainable, technologically enabled projects for our customers. The impacts of what we do are far-reaching. From helping businesses succeed by supporting their evolving workplace needs, to providing investors with superior returns for a better retirement, we're powered by the drive to go further.
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Shares in the wealth management giant have been largely stable in the last 6 months.
Everything we know about the Judo Capital Holdings IPO, plus information on how to buy in.
Everything we know about the Alloggio Group IPO, plus information on how to buy in.
Everything we know about the Larvotto Resources IPO, plus information on how to buy in.
Everything we know about the Vulcan Steel IPO, plus information on how to buy in.
Everything we know about the Artrya IPO, plus information on how to buy in.
Everything we know about the 8 Au IPO, plus information on how to buy in.
Everything we know about the Radiopharm Theranostics IPO, plus information on how to buy in.
The online retailer’s shares have lost more than half their value in the last 12 months.
